BioSpace News Archive

Forendo Pharma today announces that it has successfully completed Phase 1a study of FOR-6219, an HSD17B1 inhibitor for the treatment of endometriosis.

Apogenix announced today that it will present an overview of its HERA-ligand technology platform for cancer immunotherapy at Cambridge Healthtech Institute’s 4thAnnual Cancer Immunotherapy: Executive Summit

LGC, Biosearch Technologies proudly introduces RapiDxFire™ Thermostable RT, a truly thermostable reverse transcriptase designed specifically to meet the needs of diagnostic kit developers.

Experts from Peli BioThermal to share knowledge and industry insight at leading clinical trial conference

Gyroscope Therapeutics has dosed its first patient in Phase I/II study in dry AMD

SOTIO, a biotechnology company owned by the PPF Group, announces that final data from the SOV02 Clinical Trial with DCVAC/OvCa will be presented in the plenary session as an oral presentation at the 2019 SGO’s 50th Annual Meeting on Women’s Cancer.

Medtronic Global Holdings S.C.A. has closed a registered public offering of €500,000,000 principal amount of Floating Rate Senior Notes due 2021, €1,500,000,000 principal amount of 0.000% Senior Notes due 2021, €1,500,000,000 principal amount of 0.375% Senior Notes due 2023, €1,500,000,000 principal amount of 1.125% Senior Notes due 2027, €1,000,000,000 principal amount of 1.625% Senior Notes due 2031 and €1,000,000,000 principal amount of 2.250% Senior Notes due 2039.

Auris Medical Holding AG announced that it will provide a business update and report its financial results for the fourth quarter and full year 2018 on Thursday, March 14, 2019.

STA Pharmaceutical Co., Ltd., today announced a strategic partnership for CMC development and manufacturing.

Technology innovators in super-resolution microscopy, Amsterdam-based Confocal.nl, are running workshops on Re-scan Confocal Microscopy with demonstrations to illustrate the use of use of the technique.